Catalyst Wire Dossier Catalyst Wire Dossier

Folitime

· Gema Biotech S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Folitime, covering 2017-02-24 to 2017-02-24. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Multicentre, Open Label, Evaluator Blinded Study to Evaluate Safety and Efficacy of Folitime® of Gemabiotech S.A., Versus Gonal-f ® of Merck Serono, in Patients With Infertility Undergoing ART [Phase 3]

See pricing